KRT20 and ovarian cancer: Thus, the CK7+/CK20− immunophenotype favors primary ovarian cancer, while the CK7−/CK20+ or CK7+/CK20+ immunophenotypes (especially CK20+) favor metastatic gastrointestinal cancer.